San Jose, California (PRWEB) February 17, 2009 - Injectables represent the most vibrant and promising growth area, since downtime and recovery period is minimal to nil and costs are easy-on-the-pocket.

Surgical treatments, which provide long-term benefits, are temporality out-of-favor, especially since the US economic slowdown has tightened consumer spending on their expensive in nature, out-of-pocket surgical treatments.

Recent years have been glorious in the history of cosmetic surgery products and procedures, as new product approvals and technology improvements have strived to provide the best to the prospective patient.

Although, slightly disturbed as a result on ongoing economic meltdown, long-term forecast promise nothing but a bright future.

As the US population ages, and people have access to discretionary income, they are indeed expected to splurge on having a treatment, surgical or non-surgical.

While it is always easier to get a short of botox to smoothen wrinkles, or a dermal filler to plump up under eye hollows, demand for popular surgical treatments would continue with those for whom injections are not enough to get the desired look.

Treatments with lesser or virtually no non-surgical options such as breast augmentation leave no choice but to undergo the surgical procedure.

Surgical producers, though performed in far less numbers than non-surgical procedures, constitute the largest segment of the cosmetic surgery procedures market. Breast Augment is expected to record the fastest growth over the forecast period.

Leading growth would be non-surgical treatments. While almost all non-surgical options are expected to register healthy to above average growth, Botox will lead gains, followed by Dermal Fillers with a healthy CAGR over the forecast period.

The US cosmetic surgery products market is home to large number of companies. However, due to the diverse nature of product categories (Equipment, Injectables and Implants), not all companies are active in all market segments.

Key players include: